RxDoctor Payments Data

Irene Buckner, MD

Internal Medicine · Clarksdale, MSNPI 1003836669

Payments from drug & device makers

$1,597in general payments, 2019–2025

Across 94 payments — averaging $16.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$334
  • Lilly USA, LLC$205
  • Novo Nordisk$200
  • Pfizer$148
  • Boehringer Ingelheim$144
  • Johnson & Johnson$136
  • plus $431 from 10 others

What the payments were for

  • Food & beverage$1,597100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,597 in reported general payments places this provider in the 70th percentile of 846 internal medicine providers in Mississippi.

See all internal medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$73,871
Medicare patients
237
Services billed
904

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide97$108,582
LinzessLinaclotide144$92,077
RybelsusSemaglutide62$66,148
JanuviaSitagliptin Phosphate156$60,433
XareltoRivaroxaban152$55,832
BiktarvyBictegrav/Emtricit/Tenofov Ala12$50,482
AustedoDeutetrabenazine15$48,867
JardianceEmpagliflozin74$48,727
EliquisApixaban140$45,353
FarxigaDapagliflozin Propanediol70$37,100
Trijardy XrEmpaglifloz/Linaglip/Metformin54$34,671
EntrestoSacubitril/Valsartan37$23,928
Oxcarbazepine198$22,065
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$21,868
Janumet XrSitagliptin Phos/Metformin Hcl40$20,835

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$200$174,730159 claims
Boehringer IngelheimJardiance, Trijardy Xr, Glyxambi, Tradjenta, Synjardy$144$129,721202 claims
AbbVieLinzess, Restasis$16$96,205156 claims
MerckJanuvia, Janumet Xr$90$81,268196 claims
Johnson & JohnsonXarelto$136$55,832152 claims
PfizerEliquis$148$45,353140 claims
AstraZenecaFarxiga$334$37,10070 claims
NovartisEntresto$14$23,92837 claims
Avanir Pharmaceuticals, Inc.Nuedexta$19$18,77724 claims
Lilly USA, LLCOlanzapine$205$4,158202 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 846 internal medicine providers in Mississippi.

Other internal medicine in Clarksdale

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →